Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression
Heart and Vessels · 2024
DOI: 10.1007/s00380-024-02415-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart and Vessels, 2024. Verfasst von Hiroyuki Minato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Tottori University Faculty of Medicine, 86 Nishi-Cho, Yonago, 683-8503, Japan. Hauptthemen laut MEDLINE: Dihydropyridines, Myocytes, Cardiac, Nitric Oxide, Azetidinecarboxylic Acid. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Tottori University Faculty of Medicine, 86 Nishi-Cho, Yonago, 683-8503, Japan.
- Department of Physiology II, Kanazawa Medical University, Ishikawa, 920-0293, Japan. yasu@kanazawa-med.ac.jp.
- Department of Genomic Medicine and Regenerative Therapy, Tottori University Faculty of Medicine, Yonago, 683-8503, Japan.
- Department of Cardiovascular Medicine, and Endocrinology and Metabolism, Tottori University Faculty of Medicine, Yonago, 683-8503, Japan.
- Center for iPS Cell Research and Application, Kyoto University, Kyoto, 606-8507, Japan.
- Takeda-CiRA Joint Program (T-CiRA), Fujisawa, 251-8555, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Minato, H., Endo, R., Kurata, Y., Notsu, T., Kinugasa, Y., Wakimizu, T., Tsuneto, M., Shirayoshi, Y., Ninomiya, H., Yamamoto, K., Hisatome, I., & Otsuki, A. (2024). Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression. Heart and Vessels. https://doi.org/10.1007/s00380-024-02415-4
Vancouver
Minato H, Endo R, Kurata Y, Notsu T, Kinugasa Y, Wakimizu T, et al. Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression. Heart and Vessels. 2024. doi:10.1007/s00380-024-02415-4
BibTeX
@article{Minato2024,
author = {Minato, Hiroyuki and Endo, Ryo and Kurata, Yasutaka and Notsu, Tomomi and Kinugasa, Yoshiharu and Wakimizu, Takayuki and Tsuneto, Motokazu and Shirayoshi, Yasuaki and Ninomiya, Haruaki and Yamamoto, Kazuhiro and Hisatome, Ichiro and Otsuki, Akihiro},
title = {Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression},
journal = {Heart and Vessels},
year = {2024},
doi = {10.1007/s00380-024-02415-4}
}
EUVIMED